Monday, November 2, 2009

Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.

If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines


Get up-to-the-minute Globe Business Updates   |  More Business News
 
ADVERTISEMENT

Monday, November 2, 2009

Citizens Financial Group may be sold
By Beth Healy, Globe Staff British regulators have stepped up pressure on the Royal Bank of Scotland Group PLC to sell off assets in the wake of its massive government bailout, and the bank could be forced to sell Citizens...

Haemonetics profits up more than expected
Associated Press Haemonetics Corp. in Braintree said Monday its profit grew 22 percent in the fiscal second quarter due to improved revenue from products used in collecting blood plasma. The blood collection and processing systems maker said its profit rose...

JetBlue joins Boston College, discounts tickets today
By Jenn Abelson, Globe Staff JetBlue Airways Corp. has signed on as the official airline of Boston College Athletics, and is offering a 10 percent discount to celebrate the new partnership on all flights to or from Boston for travel...

Harvard U. will buy power from Maine wind farm
Associated Press Harvard University has entered into a 15-year agreement to buy power and renewable energy certificates from a wind energy farm to be built in Maine. Harvard officials announced Monday that Stetson Wind II facility near Danforth, Maine, expected...

Bay State Gas raises rates, but bills will go down
By Erin Ailworth, Globe Staff The Massachusetts Department of Public Utilities has given Bay State Gas Co. the go-ahead to raise distribution rates by $19 million -- about half of what the company originally requested. That increase, which took effect...

New Boston Scientific stent approved in Europe
Associated Press Medical device maker ">Boston Scientific in Natick said today it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries. The company said it will begin marketing its Promus Element stent in the European...

Pulmatrix gets $30M to fight flu and other illnesses
Lexington biotech Pulmatrix has raised $30 million to help the company develop new treatments for respiratory illnesses, according to a release from the company. ARCH Venture Partners, Novartis Bioventures Fund, Polaris Venture Partners, and 5AM Ventures participated in raising the...

Today in Globe Business
Billions in aid to banks not reaching many seeking loans Last month, Tim Burr needed $35,000 to boost his small software company, so he applied for loans at Bank of America and Citibank, both of which took billions of dollars...

No comments:

Post a Comment